⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10020192 | 1.00 | — | — | |
| SCHEMBL10799721 | 0.96 | GBA1 (0.35) | — | |
| SCHEMBL13184264 | 0.81 | — | — | |
| SCHEMBL3016074 | 0.76 | — | — | |
| SCHEMBL17798836 | 0.76 | — | — | |
| SCHEMBL19697011 | 0.76 | — | — | |
| SCHEMBL6444663 | 0.74 | — | — | |
| SCHEMBL13980015 | 0.74 | — | — | |
| Hydrochloric Acid SCHEMBL7521775 | 0.74 | GBA1 (0.31) | — | |
| SCHEMBL17652520 | 0.74 | ALDH1A1 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12297323-B2 | Polysiloxane vinylic crosslinkers with high refractive index | ALCON INC. (CH) | 2025-05-13 | — | — | US | disclosed |
| EP-4314118-B1 | POLYSILOXANE VINYLIC CROSSLINKERS WITH HIGH REFRACTIVE INDEX | ALCON INC (CH) | 2025-04-30 | — | — | EP | disclosed |
| US-11945895-B2 | Photochromic polydiorganosiloxane vinylic crosslinkers | ALCON INC. (CH) | 2024-04-02 | — | — | US | disclosed |
| EP-4118134-B1 | PHOTOCHROMIC POLYDIORGANOSILOXANE VINYLIC CROSSLINKERS | ALCON INC (CH) | 2024-02-28 | — | — | EP | disclosed |
| EP-4314118-A1 | POLYSILOXANE VINYLIC CROSSLINKERS WITH HIGH REFRACTIVE INDEX | Alcon Inc. (CH) | 2024-02-07 | — | — | EP | disclosed |
| WO-2024011921-A1 | SYNTHESIS METHOD FOR INDOLONE DERIVATIVE CONTAINING BUTENAMINE STRUCTURE | 苏州大学 | 2024-01-18 | — | — | WO | disclosed |
| WO-2024011921-A1 | SYNTHESIS METHOD FOR INDOLONE DERIVATIVE CONTAINING BUTENAMINE STRUCTURE | 苏州大学 | 2024-01-18 | — | — | WO | disclosed |
| EP-4118134-A1 | PHOTOCHROMIC POLYDIORGANOSILOXANE VINYLIC CROSSLINKERS | Alcon Inc. (CH) | 2023-01-18 | — | — | EP | disclosed |
| US-20220306810-A1 | POLYSILOXANE VINYLIC CROSSLINKERS WITH HIGH REFRACTIVE INDEX | ALCON INC. (CH) | 2022-09-29 | — | — | US | disclosed |
| WO-2022201013-A1 | POLYSILOXANE VINYLIC CROSSLINKERS WITH HIGH REFRACTIVE INDEX | ALCON INC. (CH) | 2022-09-29 | — | — | WO | disclosed |
| US-7989634-B2 | Melanocortin receptor agonists | LG LIFE SCIENCES LTD. (KR) | 2011-08-02 | — | — | US | disclosed |
| US-20100317832-A1 | AZIRIDINE ALDEHYDES, AZIRIDINE-CONJUGATED AMINO DERIVATIVES, AZIRIDINE-CONJUGATED BIOMOLECULES AND PROCESSES FOR THEIR PREPARATION | ZEALAND PHARMA A/S (DK) | 2010-12-16 | — | — | US | disclosed |
| US-20100317832-A1 | AZIRIDINE ALDEHYDES, AZIRIDINE-CONJUGATED AMINO DERIVATIVES, AZIRIDINE-CONJUGATED BIOMOLECULES AND PROCESSES FOR THEIR PREPARATION | ZEALAND PHARMA A/S (DK) | 2010-12-16 | — | — | US | disclosed |
| EP-2260041-A2 | CEPHALOTAXUS ESTERS, METHODS OF SYNTHESIS, AND USES THEREOF | Sloan Kettering Institute For Cancer Research (US) | 2010-12-15 | — | — | EP | disclosed |
| WO-2009148654-A2 | CEPHALOTAXUS ESTERS, METHODS OF SYNTHESIS, AND USES THEREOF | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 2009-12-10 | — | — | WO | disclosed |
| CN-101528825-A | Treated expanded polystyrene foam | LANXESS CORP (US) | 2009-09-09 | — | — | CN | disclosed |
| WO-2008046232-A1 | AZIRIDINE ALDEHYDES, AZIRIDINE-CONJUGATED AMINO DERIVATIVES, AZIRIDINE-CONJUGATED BIOMOLECULES AND PROCESSES FOR THEIR PREPARATION | YUDIN ANDREI K (CA) | 2008-04-24 | — | — | WO | disclosed |
| US-20070129346-A1 | Melanocortin receptor agonists | LG LIFE SCIENCES LTD. (KR) | 2007-06-07 | — | — | US | disclosed |
| US-7160449-B2 | Proline chiral columns with broad chiral selectivity | VANDERBILT UNIVERSITY (US) | 2007-01-09 | — | — | US | disclosed |
| US-20030144249-A1 | Use of organophosphorous compounds for producing a medicament for treating infections | JOMAA PHARMAKA GMBH (DE) | 2003-07-31 | — | — | US | disclosed |